Pacira BioSciences (PCRX) Long-Term Investments (2014 - 2023)
Pacira BioSciences (PCRX) posted quarterly Long-Term Investments of $2.4 million for Q4 2023, down 93.52% year-over-year from $37.2 million in Q4 2022, and down 70.9% quarter-over-quarter from $8.3 million in Q1 2023.
Pacira BioSciences (PCRX) Long-Term Investments (2014 - 2023) Analysis & Trends
Pacira BioSciences' Long-Term Investments history runs 10 years deep, the most recent figure standing at $2.4 million for Q4 2023.
- In Q4 2023, Long-Term Investments fell 93.52% year-over-year to $2.4 million; the TTM figure through Dec 2023 stood at $2.4 million (down 93.52% YoY), while the FY2023 annual figure was $2.4 million, down 93.52% from the prior year.
- Long-Term Investments for Q4 2023 stood at $2.4 million, down from $8.3 million in the prior quarter.
- The five-year high for Long-Term Investments was $70.6 million in Q3 2019, with the low at $2.4 million in Q4 2023.
- The 5-year median for Long-Term Investments is $21.4 million (2019), against an average of $25.7 million.
- The sharpest annual moves came in 2019 and 2023: Long-Term Investments soared 1484.13% in 2019, then sank 93.52% in 2023.
- Pacira BioSciences' Long-Term Investments stood at $11.0 million in 2019, then advanced by 27.78% to $14.0 million in 2020, then soared by 149.45% to $35.0 million in 2021, then grew by 6.4% to $37.2 million in 2022, then tumbled by 93.52% to $2.4 million in 2023.
- Business Quant data shows PCRX's Long-Term Investments at $2.4 million in Q4 2023, $8.3 million in Q1 2023, and $37.2 million in Q4 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.86 Bn | 42.90 Bn | - | 92.58 Mn |
| 2 | Teva Pharmaceutical Industries | 43.19 Bn | 39.54 Bn | 2.15 Bn | - |
| 3 | Zoetis | 31.46 Bn | 29.79 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.57 Bn | 22.77 Bn | 5.10 Bn | 63.23 Mn |
| 5 | United Therapeutics | 22.15 Bn | 19.49 Bn | 683.80 Mn | 1.14 Bn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | - |
| 7 | Neurocrine Biosciences | 15.50 Bn | 15.11 Bn | 935.80 Mn | 149.10 Mn |
| 8 | Elanco Animal Health | 11.71 Bn | 11.18 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.95 Bn | - | 60.00 Mn |
| 10 | Pacira BioSciences | 947.48 Mn | 696.45 Mn | 148.24 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | 2.41 Mn |
| Mar 31, 2023 | 8.28 Mn |
| Dec 31, 2022 | 37.21 Mn |
| Sep 30, 2022 | 17.39 Mn |
| Mar 31, 2021 | 34.97 Mn |
| Dec 31, 2020 | 14.02 Mn |
| Sep 30, 2020 | 44.06 Mn |
| Jun 30, 2020 | 8.26 Mn |
| Mar 31, 2020 | 35.12 Mn |
| Dec 31, 2019 | 10.97 Mn |
| Sep 30, 2019 | 70.58 Mn |
| Jun 30, 2019 | 25.36 Mn |
| Dec 31, 2018 | 25.87 Mn |
| Jun 30, 2018 | 1.60 Mn |
| Mar 31, 2018 | 21.68 Mn |
| Dec 31, 2017 | 60.05 Mn |
| Sep 30, 2017 | 80.81 Mn |
| Mar 31, 2016 | 13.47 Mn |
| Dec 31, 2015 | 13.46 Mn |
| Sep 30, 2015 | 17.92 Mn |